Evidence-based Evaluation and Mechanism of Shenhuang Granules in the Treatment of Sepsis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

July 1, 2026

Conditions
Sepsis
Interventions
DRUG

shenhuang granule

"Traditional Chinese medicine compound Shenhuang Granules is developed by Professor Fang Bangjiang, a scholar in the team of Qi-Huang, which is composed of ginseng, rhubarb, dandelion, etc., with the effect of Fuzheng Guben, clearing heat and detoxification, promoting qi and promoting blood and detumification."

DRUG

placebo

Placebo was provided by Tianjin Hongri Pharmaceutical Co., LTD., and was given orally or nasally (through gastric tube or intestinal tube) after dissolution of 100ml warm water (temperature about 40°) in 1 package twice a day.

Trial Locations (1)

310006

RECRUITING

First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou

All Listed Sponsors
collaborator

Zhejiang University

OTHER

collaborator

Red Cross Hospital, Hangzhou, China

OTHER

collaborator

Ningbo Hospital of Traditional Chinese Medicine

UNKNOWN

lead

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER